Drug name - Exparel

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11033495 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes Jan, 2041

(18 years from now)

US11179336 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes Jan, 2041

(18 years from now)

Drugs and Companies using BUPIVACAINE ingredient

Treatment: Method of providing postsurgical pain management, for example, via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia; Method of treating pain, for example, treating postsurgical pain via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia

Dosage: INJECTABLE, LIPOSOMAL;INJECTION

More Information on Dosage
Strength Dosage Availability
133MG/10ML (13.3MG/ML) INJECTABLE, LIPOSOMAL;INJECTION Prescription
266MG/20ML (13.3MG/ML) INJECTABLE, LIPOSOMAL;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.